Cetyl Myristoleate — Frequently Asked Questions
This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer
Frequently Asked Questions
How does cetyl myristoleate work for joints?
How does cetyl myristoleate work for joints?
CMO works through three proposed mechanisms: (1) as a joint lubricant by acting as a surfactant in synovial fluid, (2) as an anti-inflammatory by modulating prostaglandin production, and (3) as an immune modulator by influencing T-cell and B-cell function. The combination of these effects may explain its broad joint health benefits.
Do I need to take cetyl myristoleate continuously?
Do I need to take cetyl myristoleate continuously?
Unlike most joint supplements, CMO is often taken as a short course (30-68 days) rather than continuously. Some users report lasting benefits after a single course, possibly because CMO integrates into cell membranes for a sustained effect. However, some people repeat courses every few months as needed.
Is cetyl myristoleate well-studied compared to glucosamine?
Is cetyl myristoleate well-studied compared to glucosamine?
No. Glucosamine has dozens of large RCTs and multiple meta-analyses, while CMO has only a few small controlled trials. The existing evidence is positive but preliminary. CMO may be worth trying for people who have not responded to glucosamine or chondroitin, but it should not be considered a first-line option based on current evidence.
References
- Hesslink R, Armstrong D, Nagendran MV, et al. (2002). Cetylated fatty acids improve knee function in patients with osteoarthritis. Journal of Rheumatology. PubMed
- Kraemer WJ, Ratamess NA, Anderson JM, et al. (2004). Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis. Journal of Rheumatology. PubMed
- Diehl HW, May EL (1994). Cetyl myristoleate isolated from Swiss albino mice: an apparent protective agent against adjuvant arthritis in rats. Journal of Pharmaceutical Sciences. DOI PubMed